Xencor, Inc. (XNCR) Social Stream



Xencor, Inc. (XNCR): $29.29

-0.75 (-2.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add XNCR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 373

in industry

XENCOR INC (XNCR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering XNCR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 6 $71 $49 $57.166 $29.5 93.78%
2021-11-12 6 $71 $49 $57.833 $29.5 96.04%
2021-12-12 6 $71 $49 $58 $29.5 96.61%
2022-01-02 7 $71 $49 $58.428 $29.5 98.06%
2022-02-08 8 $71 $49 $58.625 $29.5 98.73%
2022-02-14 9 $71 $49 $58.111 $29.5 96.99%
2022-03-22 9 $71 $49 $57.375 $29.5 94.49%
2022-04-10 9 $71 $49 $57.666 $29.5 95.48%
2022-05-06 8 $66 $48 $56.375 $29.5 91.1%
2022-05-27 8 $60.001 $42 $53.375 $29.5 80.93%
2022-06-06 8 $60 $42 $53.375 $29.5 80.93%
2022-07-06 9 $60 $42 $53 $29.5 79.66%
2022-08-04 9 $60 $35 $51.555 $29.5 74.76%
2022-09-21 10 $60 $35 $50.1 $29.5 69.83%
2022-10-13 10 $60 $35 $50.1 $29.5 69.83%
2022-11-08 10 $60 $35 $48.4 $29.5 64.07%
2022-11-09 10 $60 $35 $48.2 $29.5 63.39%

The Trend in the Analyst Price Target


Over the past 15 months, XNCR's average price target has gone down $5.35.

XNCR reports an average of 91.29% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-15 7 71.000 49 58.428 36.55 59.86%
2022-05-23 8 60.001 42 53.375 22.75 134.62%
2022-05-27 8 60.001 42 53.375 22.69 135.24%
2022-08-04 9 60.000 35 51.555 29.67 73.76%
2022-10-13 10 60.000 35 49.444 27.85 77.54%

XNCR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.1 9 1 0 0 0 10

The Trend in the Broker Recommendations


XNCR's average broker recommendation rating improved by 0.01 over the prior 123 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, XENCOR INC's average analyst price target is higher than 1384.84% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, XENCOR INC's variance in analysts' estimates is lower than -423.97% of them.
  • XENCOR INC's number of analysts covering the stock is greater than 1265.36% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, XENCOR INC's upside potential (average analyst target price relative to current price) is higher than 616.24% of them.

Stocks similar to XENCOR INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PAHC, SAGE, and FGEN.

Is XNCR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.673 seconds.